ARTBIO Announces $132 Million Series B Financing to Advance Pipeline of Alpha Radioligand Therapies and Expand Manufacturing and Supply Chain Infrastructure
Financing co-led by new investors Sofinnova Investments and B Capital, along with an existing investor with continued support from F-Prime, Omega Funds, and Third Rock Ventures. Additional new investors include Qatar Investment Authority and Alexandria Venture Investments. Funding will support the advancement of lead asset AB001 through Phase II development, the progress of additional undisclosed […]





